Alpha Cognition Inc. Accretion Expense
Alpha Cognition Inc. (ACOG) reported Accretion Expense of $4.89 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2025-11-13
- Alpha Cognition Inc. accretion expense for the quarter ending 2025-09-30 was $0.00.
- Alpha Cognition Inc. accretion expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Alpha Cognition Inc. accretion expense for the quarter ending 2025-03-31 was $4.89K, a 70.54% decline year-over-year.
- Alpha Cognition Inc. accretion expense for the quarter ending 2024-12-31 was $42.75K, a 154.54% increase year-over-year.
- Alpha Cognition Inc. accretion expense for fiscal 2024 was $80.50K, a 34.67% increase from fiscal 2023.
- Alpha Cognition Inc. accretion expense for fiscal 2023 was $59.78K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 9 month as first filed | Accretion Expense 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $4.89K 10-Q · filed 2025-11-13 | $47.64K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.89K 10-Q · filed 2025-08-14 | $47.64K derived: sum of 3 quarters · filed 2025-08-14 | $47.64K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2025-03-31 | $4.89K 10-Q · filed 2025-05-15 | $47.64K derived: sum of 2 quarters · filed 2025-05-15 | $47.64K derived: sum of 3 quarters · filed 2025-11-13 | $68.79K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-12-31 | $42.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $42.75K derived: sum of 2 quarters · filed 2025-11-13 | $63.89K derived: sum of 3 quarters · filed 2025-11-13 | $80.50K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $21.14K derived: sum of 2 quarters · filed 2025-11-13 | $37.75K 10-Q · filed 2025-11-13 | $59.13K 10-Q · filed 2024-11-14 | $54.55K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $21.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $37.75K 10-Q · filed 2025-08-14 | $54.55K derived: sum of 3 quarters · filed 2025-08-14 | $71.34K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $16.61K 10-Q · filed 2025-05-15 | $33.41K derived: sum of 2 quarters · filed 2025-05-15 | $50.20K derived: sum of 3 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $16.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $33.59K derived: sum of 2 quarters · filed 2025-03-31 | $59.78K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $16.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $42.98K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $26.19K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |